848648-96-4Relevant academic research and scientific papers
Rational design, synthesis, and structure-Activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists
Lowe, Richard F.,Nelson, Jodene,Dang, Trunghau N.,Crowe, Paul D.,Pahuja, Anil,McCarthy, James R.,Grigoriadis, Dimitri E.,Conlon, Paul,Saunders, John,Chen, Chen,Szabo, Thomas,Chen, Ta Kung,Bozigian, Haig
, p. 1540 - 1549 (2007/10/03)
Following the discovery of the very high binding affinity of 4-anilinopyrimidines against corticotropin-releasing factor receptor-1 (CRF 1) (e.g., 1, Ki = 2 nM), a new series of triazoles bearing different groups has been synthesized
1-Alkyl-3-amino-5-aryl-1H-[1,2,4]triazoles: Novel synthesis via cyclization of N-Acyl-S-methylisothioureas with alkylhydrazines and their potent corticotropin-Releasing factor-1 (CRF1) receptor antagonist activities
Chen, Chen,Dagnino Jr., Raymond,Huang, Charles Q.,McCarthy, James R.,Grigoriadis, Dimitri E.
, p. 3165 - 3168 (2007/10/03)
Cyclizations of alkylhydrazines with N-acyl-S-methylisothioureas, readily synthesized from acyl chlorides, sodium thioisocyanate, dialkylamines then methyl iodide in a one-pot reaction, gave 1-alkyl-3-dialkylamino-5-phenyltriazoles 7 as major products. The regioisomers were assigned through the use of NOE NMR experiments. While bearing a N-bis(cyclopropyl)methyl-N-propylamino group, this series of compounds shows very good binding affinity on the human CRF1 receptor. Among them, 1-methyl-3-[N-bis(cyclopropyl)methyl-N-propylamino]-5-(2,4-dichlorophenyl)- 1H-[1,2,4]triazole 7a had the best binding affinity for the CRF1 receptor (Ki=9 nM).
